Research map: Cost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile

Back to the article

Papers in this map

  1. Convex Optimization · Stephen Boyd · 2004 · 57271 citations · Cited by this paper
  2. Costs and Budget Impact of a Health System Strengthening Intervention for Hypertension and Cardiovascular Disease Care in Ghana · 2026 · Related
  3. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 · Alize J Ferrari · 2024 · 5015 citations · Cited by this paper
  4. Active Transport Health Model: Valuing the Health Benefits of Active Transport · 2026 · Related
  5. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 · Jeffrey D Stanaway · 2016 · 1389 citations · Cited by this paper
  6. Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases · 2026 · Related
  7. Cost–effectiveness thresholds: pros and cons · Melanie Bertram · 2016 · 812 citations · Cited by this paper
  8. Funding Health Promotion Activities to Reduce Avoidable Hospital Admissions in Frail Older Adults (HomeHealth): Further Challenges to the “Cost-Effective but Unaffordable” Paradox · 2025 · Related
  9. Fitting dynamic models to epidemic outbreaks with quantified uncertainty: A primer for parameter uncertainty, identifiability, and forecasts · Gerardo Chowell · 2017 · 404 citations · Cited by this paper
  10. Action Plan to Better Approximate Reality in Cost-Effectiveness Analyses · 2026 · Related
  11. Structural Identifiability of Dynamic Systems Biology Models · Alejandro F. Villaverde · 2016 · 297 citations · Cited by this paper
  12. The Price of Speed: Estimating the Impact of List Prices on Time to Availability of New Medicines in 18 European Countries · 2026 · Related
  13. Convergence and regularization results for optimal control problems with sparsity functional · Gerd Wachsmuth · 2010 · 116 citations · Cited by this paper
  14. Agreement in Qualitative and Quantitative Assessments of Disease Severity: Evidence from Pharmaceutical Reimbursement in Sweden · 2026 · Related
  15. Differential Elimination for Dynamical Models via Projections with Applications to Structural Identifiability · Ruiwen Dong · 2023 · 91 citations · Cited by this paper
  16. Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study · 2025 · Related
  17. What next after GDP-based cost-effectiveness thresholds? · Y-Ling Chi · 2020 · 80 citations · Cited by this paper
  18. Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping Review · 2025 · Related
  19. HEPATITIS A · Nyingi M. Kemmer · 2000 · 75 citations · Cited by this paper
  20. Mathematical model of transmission dynamics and optimal control strategies for 2009 A/H1N1 influenza in the Republic of Korea · Soyoung Kim · 2016 · 71 citations · Cited by this paper
  21. Hepatitis A and Hepatitis E: Clinical and Epidemiological Features, Diagnosis, Treatment, and Prevention · Glynn W. Webb · 2020 · 65 citations · Cited by this paper
  22. The Cost-effectiveness of Adolescent Hepatitis A Vaccination in States With the Highest Disease Rates · R. Jake Jacobs · 2000 · 63 citations · Cited by this paper
  23. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile · María Teresa Valenzuela · 2005 · 57 citations · Cited by this paper
  24. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach · Praveen Dhankhar · 2015 · 45 citations · Cited by this paper
  25. Scaling and Balancing for High-Performance Computation of Optimal Controls · I. M. Ross · 2018 · 37 citations · Cited by this paper
  26. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations · Don Husereau · 2022 · 35 citations · Cited by this paper
  27. L2 Norm-Based Control Regularization for Solving Optimal Control Problems · Ehsan Taheri · 2023 · 28 citations · Cited by this paper
  28. Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea · Eun-Young Yim · 2012 · 22 citations · Cited by this paper
  29. Vaccination of Sexually Active Homosexual Men Against Hepatitis A: Analysis of Costs and Benefits · R. Jake Jacobs · 1999 · 20 citations · Cited by this paper
  30. Causes and countermeasures for repeated outbreaks of hepatitis A among adults in Korea · Moran Ki · 2019 · 18 citations · Cited by this paper
  31. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada · Lauren C. Ramsay · 2019 · 9 citations · Cited by this paper
  32. Cost-effective analysis of hepatitis A vaccination in Kerala state, India · Yogesh Krishnarao Gurav · 2024 · 9 citations · Cited by this paper
  33. Why cost-effectiveness thresholds for global health donors should differ from thresholds for Ministries of Health (and why it matters) · Tom Drake · 2024 · 7 citations · Cited by this paper
  34. Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study · Elamin H. Elbasha · 2021 · 6 citations · Cited by this paper
  35. A Tutorial on Structural Identifiability of Epidemic Models Using StructuralIdentifiability.jl · Yuganthi R. Liyanage · 2026 · 4 citations · Cited by this paper
  36. Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C · Richard Aycock · 2000 · 3 citations · Cited by this paper
  37. Untitled · Cited by this paper
  38. Untitled · Cited by this paper

Source: OpenAlex (CC0)